Metachronous skin cancers as an indicator of a posttransplant solid tumor in a kidney recipient

Pol Arch Intern Med. 2020 Jan 31;130(1):70-71. doi: 10.20452/pamw.15047. Epub 2019 Nov 4.

Authors

Piotr Centkowski¹, Eve Chowaniec¹, Krzysztof Okoń², Dariusz Adamek², Marek Kuźniewski¹, Katarzyna Krzanowska³

Affiliations

¹ Department of Nephrology, Jagiellonian University Medical College, Kraków, Poland
² Department of Clinical and Experimental Pathomorphology, Jagiellonian University Medical College, Kraków, Poland
³ Department of Nephrology, Jagiellonian University Medical College, Kraków, Poland. [email protected]

PMID: 31682241
DOI: 10.20452/pamw.15047

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Carcinoma, Basal Cell / etiology
Carcinoma, Basal Cell / immunology
Female
Glucocorticoids / adverse effects
Glucocorticoids / therapeutic use
Humans
Immune System / drug effects
Immunosuppressive Agents / adverse effects*
Immunosuppressive Agents / therapeutic use
Keratoacanthoma / etiology
Keratoacanthoma / immunology
Kidney Transplantation*
Mycophenolic Acid / adverse effects
Mycophenolic Acid / therapeutic use
Polycystic Kidney Diseases / surgery*
Skin Neoplasms / etiology*
Skin Neoplasms / immunology
Tacrolimus / adverse effects
Tacrolimus / therapeutic use

Substances

Glucocorticoids
Immunosuppressive Agents
Mycophenolic Acid
Tacrolimus